Predictors of six-month clinical outcome after balloon angloplasty to guide provisional stent implantation

Rob A. van Liebergen; Michiel Voskuil; Jan G.P. Tijssen; Patrick W. Serruys; Jan J. Piek

doi:10.1016/s0735-1097(02)80214-5

Related publications

Article2014

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)

Yuki Ishibashi, Yoshinobu Onuma, Sjoerd T. Nauta, Roberto Diletti, Αντώνιος Καρανάσος, Takashi Muramatsu, Evelyn Regar, Nicolas M. Van Mieghem, Peter de Jaegere, Patrick W. Serruys, Felix Zijlstra, Robert van Geuns

Journal of the American College of Cardiology

Article2005

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

Andrew T.L. Ong, Angela Hoye, Jiro Aoki, Carlos A.G. van Mieghem, Gastón A. Rodríguez-Granillo, Karel Sonnenschein, Evelyn Regar, Eugène McFadden, Georgios Sianos, Willem J. van der Giessen, Peter P.T. de Jaegere, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys

Journal of the American College of Cardiology

Article2000

Stent and stent-edge remodeling after conventional and radioactive stent implantation

I Kay, Manel Sabaté, Marco A. Costa, Ken Kozuma, Mariano Albertal, Jürgen Ligthart, V. Coen, Peter C. Levendag, Willem G. van der Giessen, Patrick W. Serruys

Heart Lung and Circulation

Article2011

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Roberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gómez‐Lara, Salvatore Brugaletta, Robert‐Jan van Geuns, Evelyn Regar, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourne, Li Dong, Susan Veldhof, Richard Rapoza, Krishnakutty Sudhir, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Journal of the American College of Cardiology

Article2003

Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy

Francesco Saia, Pedro A. Lemos, Georgios Sianos, Muzaffer Değertekin, Chi‐Hang Lee, Chourmouzios A. Arampatzis, Angela Hoye, Kengo Tanabe, Evelyn Regar, Willem J. van der Giessen, Pieter C. Smits, Pim de Feyter, Jurghen Ligthart, Ron T. van Domburg, Patrick W. Serruys

The American Journal of Cardiology

Predictors of six-month clinical outcome after balloon angloplasty to guide provisional stent implantation

Abstract

Discussion(0)

Related publications

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

Stent and stent-edge remodeling after conventional and radioactive stent implantation

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy

Predictors of six-month clinical outcome after balloon angloplasty to guide provisional stent implantation

Abstract

Discussion(0)

Related publications

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (&gt;32MM)

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

Stent and stent-edge remodeling after conventional and radioactive stent implantation

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)